Clinical trials: Pancreatic Cystic Lesion (PCL)
Pancreatic Cystic Lesions
Evaluation of PCLs Using Three EUS-FNA Needles
To document impact of EUS-FNA needle size and flexibility on effectiveness of pancreatic cystic lesions (PCL) aspiration, on ability to obtain sufficient material for standard diagnostic testing, and on diagnostic accuracy of…
- Trial name
- NCT01711294
- Testing
- 19 G Flex Needle, 22 G Needle, 19 G Needle
- Where
- 8 sites in United States, China and 1 more
- Volunteers
- 250 people
- Sponsor
- Boston Scientific Corporation
Pancreatic Cystic Lesion (PCL)
An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography
The aim of this study is to develop and validate an artificial intelligence system named iEUS-PCL (intelligent endoscopic ultrasound system-pancreatic cystic lesions） for detecting and multimodal, multi-class diagnosing…
- Trial name
- NCT07543263
- Testing
- iEUS-PCL(intelligent endoscopic ultrasound system- pancreatic cystic lesion)
- Where
- China
- Volunteers
- 176 people
- Sponsor
- Qilu Hospital of Shandong University
Pancreatic Cyst, Pancreatic Neuroendocrine Carcinoma
Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy
Pancreatic cystic lesions (PCLs) comprise of a heterogeneous group of entities that are benign, premalignant or malignant. With increased use of modern imaging techniques in recent years, incidentally discovered PCL have become…
- Conditions
- Pancreatic Cyst, Pancreatic Neuroendocrine Carcinoma, Pancreatic Pseudocyst, Pancreatic Serous Cystadenoma
- Trial name
- NCT03884179
- Volunteers
- 58 people
- Sponsor
- Sahlgrenska University Hospital